Get the up-to-date Patient Information/Informed Consent About Birth Defects (for female ... - fda 2024 now

Get Form
ipledge consent form pdf Preview on Page 1

Here's how it works

01. Edit your form online
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

How to modify Patient Information/Informed Consent About Birth Defects (for female ... - fda in PDF format online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

Adjusting paperwork with our extensive and user-friendly PDF editor is simple. Follow the instructions below to fill out Patient Information/Informed Consent About Birth Defects (for female ... - fda online easily and quickly:

  1. Sign in to your account. Log in with your email and password or register a free account to try the product before choosing the subscription.
  2. Upload a document. Drag and drop the file from your device or import it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
  3. Edit Patient Information/Informed Consent About Birth Defects (for female ... - fda. Easily add and underline text, insert pictures, checkmarks, and symbols, drop new fillable areas, and rearrange or remove pages from your paperwork.
  4. Get the Patient Information/Informed Consent About Birth Defects (for female ... - fda completed. Download your updated document, export it to the cloud, print it from the editor, or share it with others via a Shareable link or as an email attachment.

Make the most of DocHub, the most straightforward editor to rapidly handle your documentation online!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
The iPLEDGE system automatically checks patient qualification criteria for you. Prescriptions will be authorized only for those patients who meet all criteria. Additional fills for the prescription to achieve the desired dosage can be entered by the pharmacist immediately after the prescription is authorized.
The iPLEDGE Program was instituted as a replacement for the failed SMART program (System to Manage Related Teratogenicity). Instituted in April 2002, SMART aimed to eliminate -induced birth defects by preventing exposure to the drug during pregnancy.
If you missed the window during your first month of treatment, you will need to wait another 19 days before the iPledge system will allow us to enter another negative pregnancy test.
The iPLEDGE Program was originally implemented in early 2005 and approved as the iPLEDGE REMS in 2010. The goals of the iPLEDGE REMS are to prevent fetal exposure to and to inform prescribers, pharmacists, and patients about isotretinoins serious risks and safe-use conditions.
The iPLEDGE REMS is a, shared (includes multiple manufacturers) Risk Evaluation and Mitigation Strategy (REMS) with requirements for prescribers, pharmacies, patients, and wholesalers. The iPLEDGE REMS also includes a pregnancy registry for patients who get pregnant.
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

If it's biologically possible for you to become pregnant, iPLEDGE requires you to agree to using two forms of birth control. This is usually required regardless of your sexual orientation, gender identity, or level of sexual activity.
Answer: The iPLEDGE program is an FDA required risk management program with the goal of preventing fetal exposure to .
The iPLEDGE REMS is a safety program to manage the risk of isotretinoins teratogenicity and to minimize fetal exposure. The REMS is required by the U.S. Food and Drug Administration (FDA) to ensure the benefits of outweigh its risks.
Focus Area. The oral contraceptive pill and female sterilization are the most widely used birth control methods in the United States, according to the most recent data available from the U.S. Centers for Disease Control and Prevention (CDC).
obtain prescription The confidential iPLEDGE Program Pregnancy Registry is a way to collect that information. It may help us prevent more pregnancies in the future. Your doctor/prescriber will tell you about the confidential iPLEDGE Program Pregnancy Registry.

Related links